Seralutinib
| CAS No. | 1619931-27-9 | Cat. No. | BCP39880 |
| Name | Seralutinib | ||
| Synonyms | PK-10571; PK10571; PK 10571; GB002; GB-002; GB 002; | ||
| Formula | C27H27N5O3 | M. Wt | 469.54 |
| Description | Seralutinibm, also known as PK-10571 and GB002, is a Novel Inhaled PDGFR Kinase Inhibitor. Seralutinib demonstrates efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah). Localized delivery of GB002 is efficacious on multiple measures of disease activity in the SU5416/H model. GB002 treatment is associated with disease remodeling including improved cardiopulmonary hemodynamics, reduced pulmonary arteriolar muscularization, restoration of BMPR2 signaling, reduced NT-proBNP and improved cytokines. | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.